Clinical trial Recruiting at 1 site Interventional Ages 28 Days and up

Switching preterm infants from donor human milk to preterm formula

Official title: Transition From Donor Milk: a Feasibility Study

Run by Augusta University · NCT06514014 · Data updated 2026-11-12

This study will try switching preterm and very low birth weight infants who are at least 28 days old and currently on donor human milk to a preterm infant formula to see if they gain weight and length faster and build more fat-free mass.

Quick facts

Study typeInterventional
Ages28 Days and up
SexAll
Enrollment20 (estimated)
SponsorAugusta University
Academic / other
Locations1 site (Augusta, Georgia)
StatusRecruiting
StartedMay 1, 2025
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedAugust 24, 2025
Trial IDNCT06514014 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are preterm infants over 1,250 g who are at least 28 days old and currently receiving donor human milk (with or without mother's milk) and who do not have major gastrointestinal disease or congenital anomalies.

Probably not a fit

Infants with birth weight below the 5th percentile, a history of NEC or intestinal perforation, significant congenital anomalies, or for whom the care team advises against switching may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center interventional feasibility study enrolling preterm infants (>1250 g and ≥28 days old) whose diet is primarily donor human milk. Enrolled infants will be transitioned from donor human milk to a preterm infant formula after the first month of life. Investigators will monitor growth outcomes (weight, length) and body composition (fat-free mass) as well as safety events such as feeding intolerance. The study is conducted at Wellstar-MCG in Augusta, Georgia, under Augusta University sponsorship.

Why it matters

Potential benefit: If successful, switching to preterm formula after the first month could lead to faster weight and length gains and greater lean mass accumulation while remaining safe.

How similar studies have gone: There are limited clinical data guiding the optimal duration of donor human milk in preterm infants, and while formula feeding can increase short-term growth, this specific transition strategy has not been well tested in prior trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Greater than 1,250 grams
2. At least 28 days of life
3. Diet consisting of donor human milk with/without mother's own milk

Exclusion Criteria:

1. Birth weight below the 5th percentile
2. History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder
3. Congenital anomalies
4. Care team discretion

Where it's running

  • Wellstar-MCG
    Augusta, Georgia, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.